T

Tessera Therapeutics

312 employees

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Genetics
Biopharma
Life Science

Date founded

2018

Funding rounds raised

Total raised

$300M

from 11 investors over 11 rounds

T

Tessera Therapeutics raised $300M on April 19, 2022

Investors: Longevity Vision Fund, ARTIS Ventures, Flagship Ventures, SoftBank Investment Advisers, March Capital and T. Rowe Price

T

Tessera Therapeutics raised $230M on January 12, 2021

Investors: Longevity Vision Fund, Alaska Permanent Fund Corporation, Qatar Investment Authority, SoftBank Investment Advisers and Flagship Ventures

FAQ